NCT05452798View on ClinicalTrials.gov

A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark

CompletedOBSERVATIONAL
Enrollment

1,054

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Breast Cancer
Trial Locations (1)

Unknown

Danish Breast Cancer Group, Copenhagen

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05452798 - A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark | Biotech Hunter | Biotech Hunter